AllianceBernstein
HRMY icon

AllianceBernstein’s Harmony Biosciences HRMY Stock Holding History

AllianceBernstein’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.95M Sell
141,010
-3,335
-2% -$105K ﹤0.01% 1674
2026
Q1 		$5.4M Sell
144,345
-25,305
-15% -$830K ﹤0.01% 1505
2025
Q4 		$6.35M Buy
169,650
+630
+0.4% +$20.7K ﹤0.01% 1425
2025
Q3 		$4.66M Buy
169,020
+16,680
+11% +$575K ﹤0.01% 1548
2025
Q2 		$4.81M Buy
152,340
+9,610
+7% +$309K ﹤0.01% 1496
2025
Q1 		$4.74M Buy
142,730
+19,680
+16% +$705K ﹤0.01% 1469
2024
Q4 		$4.23M Hold
123,050
– – ﹤0.01% 1561
2024
Q3 		$4.92M Sell
123,050
-32,460
-21% -$1.14M ﹤0.01% 1521
2024
Q2 		$4.69M Hold
155,510
– – ﹤0.01% 1514
2024
Q1 		$5.22M Sell
155,510
-10,597
-6% -$340K ﹤0.01% 1445
2023
Q4 		$5.37M Buy
166,107
+19,827
+14% +$553K ﹤0.01% 1463
2023
Q3 		$4.79M Buy
146,280
+63,910
+78% +$2.22M ﹤0.01% 1447
2023
Q2 		$2.9M Sell
82,370
-19,076
-19% -$659K ﹤0.01% 1693
2023
Q1 		$3.31M Buy
101,446
+45,623
+82% +$2.08M ﹤0.01% 1585
2022
Q4 		$3.08M Buy
55,823
+23,977
+75% +$1.32M ﹤0.01% 1657
2022
Q3 		$1.41M Sell
31,846
-3,338
-9% -$163K ﹤0.01% 2111
2022
Q2 		$1.72M Buy
35,184
+3,549
+11% +$160K ﹤0.01% 2039
2022
Q1 		$1.54M Sell
31,635
-299
-0.9% -$12.2K ﹤0.01% 2234
2021
Q4 		$1.36M Buy
31,934
+22,634
+243% +$902K ﹤0.01% 2349
2021
Q3 		$356K Sell
9,300
-5,400
-37% -$174K ﹤0.01% 2900
2021
Q2 		$415K Buy
+14,700
New +$441K ﹤0.01% 2893

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AllianceBernstein's HRMY Position: Q2 2026 in Review

AllianceBernstein reduced its Harmony Biosciences (HRMY) stake by 2.3% in Q2 2026, selling an estimated $105K and leaving 141,010 shares worth $3.95M. The position accounts for ﹤0.01% of the portfolio, ranked #1674.

AllianceBernstein first reported a position in HRMY in Q2 2021 and has held it in 21 quarters since. The position peaked at $6.35M in Q4 2025. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • AllianceBernstein held 141,010 shares of Harmony Biosciences worth $3.95M as of Q2 2026.
  • AllianceBernstein sold 3,335 Harmony Biosciences shares in Q2 2026, an estimated $105K.
  • Harmony Biosciences made up ﹤0.01% of AllianceBernstein's portfolio in Q2 2026, its #1674 holding.
  • AllianceBernstein first reported a position in Harmony Biosciences in Q2 2021 and has held it in 21 quarters since.
  • AllianceBernstein's Harmony Biosciences position peaked at $6.35M in Q4 2025.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.